Director
DIN: 09092483
Kiranben Ajay Vasu is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at DVAAN PHARMACEUTICAL INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09092483.Kiranben Ajay Vasu has previously been associated with 1 company in roles such as Director.Kiranben Ajay Vasu is currently involved in 2 different roles. Their most recent position is with DVAAN PRODUCTION LLP as a Designated Partner. The first company Kiranben Ajay Vasu was appointed to as a director was DVAAN PHARMACEUTICAL INDIA PRIVATE LIMITED. Kiranben Ajay Vasu is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Kiranben Ajay Vasu is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at DVAAN PHARMACEUTICAL INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09092483.Kiranben Ajay Vasu has previously been associated with 1 company in roles such as Director.Kiranben Ajay Vasu is currently involved in 2 different roles. Their most recent position is with DVAAN PRODUCTION LLP as a Designated Partner. The first company Kiranben Ajay Vasu was appointed to as a director was DVAAN PHARMACEUTICAL INDIA PRIVATE LIMITED. Kiranben Ajay Vasu is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 1m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| DVAAN PHARMACEUTICAL INDIA PRIVATE LIMITED | Director | 15-Sep-2023 |